Related Experiment Video
Updated: Aug 16, 2025

RhoC GTPase Activation Assay
Published on: August 22, 2010
SGOL2 promotes prostate cancer progression by inhibiting RAB1A ubiquitination
Tingting Lv1, Dongwei He1, Xiaokuan Zhang1
1Department of Immuno-Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei, P.R. China.
Abstract:
Prostate cancer is the most prevalent genitourinary malignant cancer in men worldwide. Patients with prostate cancer who progress to castration-resistant prostate cancer (CRPC) or metastatic CRPC have significantly poorer survival. Advanced prostate cancer is a clinical challenge due to the lack of effective treatment strategies. In the field of oncology, SGOL2 was an emerging and differentially expressed molecule, which enhanced the proliferation of cell populations in vitro in our studies. Mass spectrum and Co-IP validated the interaction of SGOL2 and RAB1A in a protein-protein manner. We further investigated the role of SGOL2 in the regulatory mechanism of RAB1A in prostate cancer cell lines. Furthermore, SGOL2 regulated RAB1A expression by inhibiting its ubiquitination. Rescue Experiments demonstrated that SGOL2 promoted prostate cancer cell proliferation and migration by upregulating RAB1A expression. Finally, we found that SGOL2 and RAB1A may regulate the tumor microenvironment (TME) in prostate cancer. In conclusion, our findings concluded that SGOL2 stabilized RAB1A expression to promote prostate cancer development. Both of them were of great importance in TME modulation.
Insights
SGOL2 stabilizes RAB1A expression by inhibiting its ubiquitination, promoting prostate cancer cell proliferation and migration. These proteins are crucial for modulating the tumor microenvironment in advanced prostate cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Prostate cancer, particularly castration-resistant prostate cancer (CRPC), presents a significant clinical challenge with limited effective treatments.
- SGOL2 is an emerging molecule implicated in cancer cell proliferation.
Purpose of the Study:
- To investigate the role of SGOL2 in prostate cancer progression.
- To elucidate the regulatory mechanism between SGOL2 and RAB1A in prostate cancer cell lines.
Main Methods:
- Mass spectrometry and Co-immunoprecipitation (Co-IP) to validate protein-protein interactions.
- In vitro studies using prostate cancer cell lines to assess proliferation and migration.
- Ubiquitination assays and rescue experiments to confirm regulatory pathways.
Main Results:
- SGOL2 interacts with RAB1A at a protein-protein level.
- SGOL2 inhibits RAB1A ubiquitination, leading to its stabilization.
- Upregulation of RAB1A by SGOL2 promotes prostate cancer cell proliferation and migration.
- SGOL2 and RAB1A play a role in modulating the tumor microenvironment (TME).
Conclusions:
- SGOL2 stabilizes RAB1A expression, thereby promoting prostate cancer development.
- Both SGOL2 and RAB1A are critical for tumor microenvironment modulation in prostate cancer.
Related Concept Videos
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab Cascades
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

